MDPI and ACS Style
Alvarez-Mora, M.I.; Agusti, I.; Wijngaard, R.; Martinez-Barrios, E.; Barcos, T.; Borras, A.; Peralta, S.; Guimera, M.; Goday, A.; Manau, D.;
et al. Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI). J. Clin. Med. 2022, 11, 2186.
https://doi.org/10.3390/jcm11082186
AMA Style
Alvarez-Mora MI, Agusti I, Wijngaard R, Martinez-Barrios E, Barcos T, Borras A, Peralta S, Guimera M, Goday A, Manau D,
et al. Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI). Journal of Clinical Medicine. 2022; 11(8):2186.
https://doi.org/10.3390/jcm11082186
Chicago/Turabian Style
Alvarez-Mora, Maria Isabel, Ines Agusti, Robin Wijngaard, Estefania Martinez-Barrios, Tamara Barcos, Aina Borras, Sara Peralta, Marta Guimera, Ana Goday, Dolors Manau,
and et al. 2022. "Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI)" Journal of Clinical Medicine 11, no. 8: 2186.
https://doi.org/10.3390/jcm11082186